PowerShow.com - The best place to view and share online presentations
  • Help
  • Preferences
  • Sign up
  • Log in
Advanced
Free template

Nonclinical Studies PowerPoint PPT Presentations

Grid List
All Time
All TimeAdded TodayAdded This WeekAdded This Month
Show:
Recommended
RecommendedRelevanceLatestHighest RatedMost Viewed
Sort by:
Featured Presentations
Search Results
PDF Read Online Good Laboratory Practice for Nonclinical Studies (ISSN PowerPoint PPT Presentation
PDF Read Online Good Laboratory Practice for Nonclinical Studies (ISSN - 3 minutes ago - COPY LINK TO DOWNLOAD = flip.ebookmarket.pro/psjul24/B0BMCQ4N4P | get [PDF] Download Good Laboratory Practice for Nonclinical Studies (ISSN) | The GLP regulations have been enacted since 1978 and are currently under a proposed FDA amendment to revise terminology and accommodate other changes relating to advances in technology related to the industry. This book provides a unique opportunity to access interpretation of the 21CFR58 regulatory requirements from leading industry experts with a vast knowledge and expertise in their fields. The approach used takes the regulations, provides interpretations and references to examples and regulatory actions. Data integrity and the use of electronic systems in compliance with 21CFR11 Electronic Records: Electronic Signatures are also discussed.• Unique volume covering FDA inspe
3 minutes ago - COPY LINK TO DOWNLOAD = flip.ebookmarket.pro/psjul24/B0BMCQ4N4P | get [PDF] Download Good Laboratory Practice for Nonclinical Studies (ISSN) | The GLP regulations have been enacted since 1978 and are currently under a proposed FDA amendment to revise terminology and accommodate other changes relating to advances in technology related to the industry. This book provides a unique opportunity to access interpretation of the 21CFR58 regulatory requirements from leading industry experts with a vast knowledge and expertise in their fields. The approach used takes the regulations, provides interpretations and references to examples and regulatory actions. Data integrity and the use of electronic systems in compliance with 21CFR11 Electronic Records: Electronic Signatures are also discussed.• Unique volume covering FDA inspe
| PowerPoint PPT presentation | free to download
Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science Introduction PowerPoint PPT Presentation
Nonclinical Studies Subcommittee Advisory Committee for Pharmaceutical Science Introduction - Gaithersburg Hilton. December 14, 1999. T:NCSS121499.PPT. Nonclinical Studies Subcommittee ... To provide advice on improved scientific approaches to ...
Gaithersburg Hilton. December 14, 1999. T:NCSS121499.PPT. Nonclinical Studies Subcommittee ... To provide advice on improved scientific approaches to ...
| PowerPoint PPT presentation | free to view
Nonclinical Perspective on Initiating Phase 1 Studies for Biological Oncology Products PowerPoint PPT Presentation
Nonclinical Perspective on Initiating Phase 1 Studies for Biological Oncology Products - Discuss the review of nonclinical safety data for an initial IND ... Assist in gaining comment on revisions to nonclinical recommendations for safety ...
Discuss the review of nonclinical safety data for an initial IND ... Assist in gaining comment on revisions to nonclinical recommendations for safety ...
| PowerPoint PPT presentation | free to view
Safety Pharmacology Society Webinar Series: Safety Pharmacology Endpoints: Integration into Toxicology Studies Integrating functional CNS observations into toxicology studies: the CONS! Will Redfern, PhD PowerPoint PPT Presentation
Safety Pharmacology Society Webinar Series: Safety Pharmacology Endpoints: Integration into Toxicology Studies Integrating functional CNS observations into toxicology studies: the CONS! Will Redfern, PhD - Safety Pharmacology Society Webinar Series: Safety Pharmacology Endpoints: Integration into Toxicology Studies Integrating functional CNS observations into toxicology ...
Safety Pharmacology Society Webinar Series: Safety Pharmacology Endpoints: Integration into Toxicology Studies Integrating functional CNS observations into toxicology ...
| PowerPoint PPT presentation | free to download
IND Case Studies PowerPoint PPT Presentation
IND Case Studies - Sponsor agreed to address FDA concerns ... FDA provides a written response to ... clarification at meeting of FDA written responses and additional comments ...
Sponsor agreed to address FDA concerns ... FDA provides a written response to ... clarification at meeting of FDA written responses and additional comments ...
| PowerPoint PPT presentation | free to view
Top-Quality Michigan (MI) Dental Clinical/Nonclinical Limited License Practice Course PowerPoint PPT Presentation
Top-Quality Michigan (MI) Dental Clinical/Nonclinical Limited License Practice Course - About the Service: The guided study system features hands-on skills and drills developed by leading IT experts. Customizable tests allow you to focus on your weakest areas. Electronic flashcards help reinforce key concepts. Whether you are studying at home or traveling, Exam Mastery gets you ready for exam-day success! The program will calculate their score/percentile on the same questions that will appear on the actual certification exam when taken at the testing center. With that information, you'll be able to prepare yourself for what's ahead in your exam. Prepare for your certification exam with a targeted, self-paced learning program. Exam Learning Program is an easy-to-use online program designed to help you prepare for your exam and then increase your chances of passing it.
About the Service: The guided study system features hands-on skills and drills developed by leading IT experts. Customizable tests allow you to focus on your weakest areas. Electronic flashcards help reinforce key concepts. Whether you are studying at home or traveling, Exam Mastery gets you ready for exam-day success! The program will calculate their score/percentile on the same questions that will appear on the actual certification exam when taken at the testing center. With that information, you'll be able to prepare yourself for what's ahead in your exam. Prepare for your certification exam with a targeted, self-paced learning program. Exam Learning Program is an easy-to-use online program designed to help you prepare for your exam and then increase your chances of passing it.
| PowerPoint PPT presentation | free to download
NonClinical Toxicology of AntiCancer Drugs PowerPoint PPT Presentation
NonClinical Toxicology of AntiCancer Drugs - European Phase I studies can be supported by rodent data alone ... One third rodent LD10 or one third dog TDH would have predicted starting human ...
European Phase I studies can be supported by rodent data alone ... One third rodent LD10 or one third dog TDH would have predicted starting human ...
| PowerPoint PPT presentation | free to view
Top-Quality Michigan (MI) Dental Hygienist, Clinical/Nonclinical (R.D.H.) License Practice Course PowerPoint PPT Presentation
Top-Quality Michigan (MI) Dental Hygienist, Clinical/Nonclinical (R.D.H.) License Practice Course - About the Service: The guided study system features hands-on skills and drills developed by leading IT experts. Customizable tests allow you to focus on your weakest areas. Electronic flashcards help reinforce key concepts. Whether you are studying at home or traveling, Exam Mastery gets you ready for exam-day success! The program will calculate their score/percentile on the same questions that will appear on the actual certification exam when taken at the testing center. With that information, you'll be able to prepare yourself for what's ahead in your exam. Prepare for your certification exam with a targeted, self-paced learning program. Exam Learning Program is an easy-to-use online program designed to help you prepare for your exam and then increase your chances of passing it.
About the Service: The guided study system features hands-on skills and drills developed by leading IT experts. Customizable tests allow you to focus on your weakest areas. Electronic flashcards help reinforce key concepts. Whether you are studying at home or traveling, Exam Mastery gets you ready for exam-day success! The program will calculate their score/percentile on the same questions that will appear on the actual certification exam when taken at the testing center. With that information, you'll be able to prepare yourself for what's ahead in your exam. Prepare for your certification exam with a targeted, self-paced learning program. Exam Learning Program is an easy-to-use online program designed to help you prepare for your exam and then increase your chances of passing it.
| PowerPoint PPT presentation | free to download
Top-Quality Michigan (MI) Dental Assistant, Clinical/Nonclinical Limited (R.D.A.) License Practice Course PowerPoint PPT Presentation
Top-Quality Michigan (MI) Dental Assistant, Clinical/Nonclinical Limited (R.D.A.) License Practice Course - About the Service: The guided study system features hands-on skills and drills developed by leading IT experts. Customizable tests allow you to focus on your weakest areas. Electronic flashcards help reinforce key concepts. Whether you are studying at home or traveling, Exam Mastery gets you ready for exam-day success! The program will calculate their score/percentile on the same questions that will appear on the actual certification exam when taken at the testing center. With that information, you'll be able to prepare yourself for what's ahead in your exam. Prepare for your certification exam with a targeted, self-paced learning program. Exam Learning Program is an easy-to-use online program designed to help you prepare for your exam and then increase your chances of passing it.
About the Service: The guided study system features hands-on skills and drills developed by leading IT experts. Customizable tests allow you to focus on your weakest areas. Electronic flashcards help reinforce key concepts. Whether you are studying at home or traveling, Exam Mastery gets you ready for exam-day success! The program will calculate their score/percentile on the same questions that will appear on the actual certification exam when taken at the testing center. With that information, you'll be able to prepare yourself for what's ahead in your exam. Prepare for your certification exam with a targeted, self-paced learning program. Exam Learning Program is an easy-to-use online program designed to help you prepare for your exam and then increase your chances of passing it.
| PowerPoint PPT presentation | free to download
Clinical Perspective: Implications of NonClinical Findings of AnestheticInduced Neurotoxicity PowerPoint PPT Presentation
Clinical Perspective: Implications of NonClinical Findings of AnestheticInduced Neurotoxicity - Associate Professor of Anaesthesia, Harvard Medical School ... sulpicio.soriano@childrens.harvard.edu ' ... Boston Circulatory Arrest Study. Newburger et al ...
Associate Professor of Anaesthesia, Harvard Medical School ... sulpicio.soriano@childrens.harvard.edu ' ... Boston Circulatory Arrest Study. Newburger et al ...
| PowerPoint PPT presentation | free to view
Basic nonclinical requirements for registration of new drugs' PowerPoint PPT Presentation
Basic nonclinical requirements for registration of new drugs' - ... given scope and duration as well as marketing authorization for pharmaceuticals ... therapy: plasmid DNA, viral , non-viral vectors, genetically modified viruses , ...
... given scope and duration as well as marketing authorization for pharmaceuticals ... therapy: plasmid DNA, viral , non-viral vectors, genetically modified viruses , ...
| PowerPoint PPT presentation | free to view
Psychological Correlates of Perceived Stigma in a NonClinical Sample PowerPoint PPT Presentation
Psychological Correlates of Perceived Stigma in a NonClinical Sample - ... the experience of stigma e.g. Lee et al. (2005) have found ... and guilt in first-episode schizophrenia and schizoaffective disorders. ... 35(2), 211- 221 ...
... the experience of stigma e.g. Lee et al. (2005) have found ... and guilt in first-episode schizophrenia and schizoaffective disorders. ... 35(2), 211- 221 ...
| PowerPoint PPT presentation | free to view
Nonclinical Pharmacology Toxicology Data for PROTOPIC Tacrolimus ointment for Atopic Dermatitis PowerPoint PPT Presentation
Nonclinical Pharmacology Toxicology Data for PROTOPIC Tacrolimus ointment for Atopic Dermatitis - Mammalian in vitro mutagenesis assay (Chinese hamster lung-derived cells) ... To determine in a hairless mouse model if dermal test article application ...
Mammalian in vitro mutagenesis assay (Chinese hamster lung-derived cells) ... To determine in a hairless mouse model if dermal test article application ...
| PowerPoint PPT presentation | free to view
UPDATE: Nonclinical Reproductive Toxicity Information in Assessing Human Risk Joseph J. DeGeorge Ph. PowerPoint PPT Presentation
UPDATE: Nonclinical Reproductive Toxicity Information in Assessing Human Risk Joseph J. DeGeorge Ph. - Ed Fisher. Abby Jacobs. David Morse. Mercedes Serabian ... Ed Fisher. Alex Jordan. Robin Huff. David Morse. Amy Nostrandt. Krishan Raheja. Mercedes Serabian ...
Ed Fisher. Abby Jacobs. David Morse. Mercedes Serabian ... Ed Fisher. Alex Jordan. Robin Huff. David Morse. Amy Nostrandt. Krishan Raheja. Mercedes Serabian ...
| PowerPoint PPT presentation | free to view
What has the TGN1412 incident done for the conduct of Phase I studies in Europe PowerPoint PPT Presentation
What has the TGN1412 incident done for the conduct of Phase I studies in Europe - Pure Food and Drug Act - 1906. Upton Sinclair's 'The Jungle' Food, Drug, and Cosmetic Act - 1933 ... Agreed to change scope and tone of the guidance. Risk is a ...
Pure Food and Drug Act - 1906. Upton Sinclair's 'The Jungle' Food, Drug, and Cosmetic Act - 1933 ... Agreed to change scope and tone of the guidance. Risk is a ...
| PowerPoint PPT presentation | free to view
Advisory Committee for Pharmaceutical Sciences PowerPoint PPT Presentation
Advisory Committee for Pharmaceutical Sciences - PTCC Research Subcommittee identifies topical scientific areas to CDER's Pharm ... sumer. Rep. EWG 1. EWG 2. EWG 3. NonClinical. Studies Subcommittee ...
PTCC Research Subcommittee identifies topical scientific areas to CDER's Pharm ... sumer. Rep. EWG 1. EWG 2. EWG 3. NonClinical. Studies Subcommittee ...
| PowerPoint PPT presentation | free to view
Study Data Reviewer PowerPoint PPT Presentation
Study Data Reviewer - Study Data Reviewer s Guide (SDRG): Recommendations on Use of the Clinical SDRG Model for Nonclinical Data Submission Nonclinical Working Group, SDRG Project PP09
Study Data Reviewer s Guide (SDRG): Recommendations on Use of the Clinical SDRG Model for Nonclinical Data Submission Nonclinical Working Group, SDRG Project PP09
| PowerPoint PPT presentation | free to download
Molecule to Market: Safety Assessment Michael J Santostefano, PhD, DABT Head, Drug Development Toxic PowerPoint PPT Presentation
Molecule to Market: Safety Assessment Michael J Santostefano, PhD, DABT Head, Drug Development Toxic - Phase I studies Human Pharmacology studies ... NIEHS- www.niehs.nih.gov. USEPA - www.usajobs.opm.gov. ACT - www.actox.org. Interview Websites ...
Phase I studies Human Pharmacology studies ... NIEHS- www.niehs.nih.gov. USEPA - www.usajobs.opm.gov. ACT - www.actox.org. Interview Websites ...
| PowerPoint PPT presentation | free to view
Challenges of Pharmacokinetic/Pharmacodynamic Assessments in Pediatric Oncology PowerPoint PPT Presentation
Challenges of Pharmacokinetic/Pharmacodynamic Assessments in Pediatric Oncology - Summary of results of early clinical pharmacokinetic studies with ... PK guided TPT dosing: upfront window therapy (Phase II) in children with high ...
Summary of results of early clinical pharmacokinetic studies with ... PK guided TPT dosing: upfront window therapy (Phase II) in children with high ...
| PowerPoint PPT presentation | free to view
FDAs Antiviral Drugs Advisory Committee Meeting PowerPoint PPT Presentation
FDAs Antiviral Drugs Advisory Committee Meeting - Woodchuck Model. WHBV Woodchuck Hepatitis B Virus. Predictive model of HBV antivirals in humans ... Woodchuck Studies: Survival. Animals Surviving. to Age 4 ...
Woodchuck Model. WHBV Woodchuck Hepatitis B Virus. Predictive model of HBV antivirals in humans ... Woodchuck Studies: Survival. Animals Surviving. to Age 4 ...
| PowerPoint PPT presentation | free to view
What is the Role of Drug Metabolism and Pharmacokinetics (DMPK) in Drug Discovery PowerPoint PPT Presentation
What is the Role of Drug Metabolism and Pharmacokinetics (DMPK) in Drug Discovery - In drug discovery and development, we utilize Drug Metabolism and Pharmacokinetic (DMPK) studies for the assessment of bioavailability, half-life, metabolic properties, and clearance profile of a given drug compound.
In drug discovery and development, we utilize Drug Metabolism and Pharmacokinetic (DMPK) studies for the assessment of bioavailability, half-life, metabolic properties, and clearance profile of a given drug compound.
| PowerPoint PPT presentation | free to download
Robert Ball, MD, MPH, ScM PowerPoint PPT Presentation
Robert Ball, MD, MPH, ScM - Evaluate pre-licensure clinical, nonclinical, product, and manufacturing data, ... blood, and tissues (epidemiologists, clinical/product reviewers, compliance ...
Evaluate pre-licensure clinical, nonclinical, product, and manufacturing data, ... blood, and tissues (epidemiologists, clinical/product reviewers, compliance ...
| PowerPoint PPT presentation | free to view
How Do I Get Into Phase 1 Trials With My Compound? PowerPoint PPT Presentation
How Do I Get Into Phase 1 Trials With My Compound? - How Many Approaches To An IND Drug Combinations Nonclinical development programs should be conducted on the individual entities. ...
How Many Approaches To An IND Drug Combinations Nonclinical development programs should be conducted on the individual entities. ...
| PowerPoint PPT presentation | free to download
Preclinical Evaluation of Cell and Gene Therapy Products PowerPoint PPT Presentation
Preclinical Evaluation of Cell and Gene Therapy Products - Pharmacology/Toxicology Staff in OCTGT/DCEPT ... Toxicology profile ... Regulatory Expectations for Toxicology Studies. 21 CFR 312.23: IND Content and Format ...
Pharmacology/Toxicology Staff in OCTGT/DCEPT ... Toxicology profile ... Regulatory Expectations for Toxicology Studies. 21 CFR 312.23: IND Content and Format ...
| PowerPoint PPT presentation | free to view
FDA GLP Requirements for Analytical Instrumentation PowerPoint PPT Presentation
FDA GLP Requirements for Analytical Instrumentation - The GLP regulation is intended to assure that nonclinical study ... C contemporaneous. O original. A accurate. Data trails must be clear and traceable ...
The GLP regulation is intended to assure that nonclinical study ... C contemporaneous. O original. A accurate. Data trails must be clear and traceable ...
| PowerPoint PPT presentation | free to view
TENOFOVIR DF PowerPoint PPT Presentation
TENOFOVIR DF - Four Week Gavage Studies. Doses up to 500 mg/kg/day in rats. Little toxicity seen ... 42 Week Gavage Study ... Toxicity in Dog 42 Week Gavage Study ...
Four Week Gavage Studies. Doses up to 500 mg/kg/day in rats. Little toxicity seen ... 42 Week Gavage Study ... Toxicity in Dog 42 Week Gavage Study ...
| PowerPoint PPT presentation | free to view
Webinar On Good Laboratory Practice Regulations PowerPoint PPT Presentation
Webinar On Good Laboratory Practice Regulations - This webinar is a must for those personnel that require an understanding of the regulations governing laboratory activities relative to nonclinical testing that support or are intended to support applications for products regulated by FDA.
This webinar is a must for those personnel that require an understanding of the regulations governing laboratory activities relative to nonclinical testing that support or are intended to support applications for products regulated by FDA.
| PowerPoint PPT presentation | free to download
Cognitive Vulnerability Constructs in Beckian and Hopelessness Models of Depression: A Gender Compar PowerPoint PPT Presentation
Cognitive Vulnerability Constructs in Beckian and Hopelessness Models of Depression: A Gender Compar - Cognitive Vulnerability Constructs in Beckian and Hopelessness Models of ... No investigation of a diathesis-stress component of the theories. Nonclinical sample ...
Cognitive Vulnerability Constructs in Beckian and Hopelessness Models of ... No investigation of a diathesis-stress component of the theories. Nonclinical sample ...
| PowerPoint PPT presentation | free to view
OUTLINE PowerPoint PPT Presentation
OUTLINE - Reports indicate that DHEA has been shown to be chemoprotective or carcinogenic ... DHEA may be inhibitory or stimulatory to hormone sensitive tumors ...
Reports indicate that DHEA has been shown to be chemoprotective or carcinogenic ... DHEA may be inhibitory or stimulatory to hormone sensitive tumors ...
| PowerPoint PPT presentation | free to download
FDA Advisory Committee Meeting  PowerPoint PPT Presentation
FDA Advisory Committee Meeting - ... SonoVue administration and ultrasound exposure at high acoustic pressure ... (1 and 5 mL/kg) and exposed to ultrasound at high acoustic pressure (up to MI 1.9) ...
... SonoVue administration and ultrasound exposure at high acoustic pressure ... (1 and 5 mL/kg) and exposed to ultrasound at high acoustic pressure (up to MI 1.9) ...
| PowerPoint PPT presentation | free to download
Toxicology in Drug Development Lynnda Reid, Ph.D PowerPoint PPT Presentation
Toxicology in Drug Development Lynnda Reid, Ph.D - Toxicology in Drug Development Lynnda Reid, Ph.D. Pharmacology/Toxicology Reviewer Center for Drug Evaluation and Research (CDER) Rafael Ponce, Ph.D., DABT
Toxicology in Drug Development Lynnda Reid, Ph.D. Pharmacology/Toxicology Reviewer Center for Drug Evaluation and Research (CDER) Rafael Ponce, Ph.D., DABT
| PowerPoint PPT presentation | free to view
Pulmonary-Allergy Drugs Advisory Committee PowerPoint PPT Presentation
Pulmonary-Allergy Drugs Advisory Committee - ... (tacrolimus ) ointment (12-8-00 ... model if dermal test article application combined with simulated sunlight exposure can reduce the time to formation of skin ...
... (tacrolimus ) ointment (12-8-00 ... model if dermal test article application combined with simulated sunlight exposure can reduce the time to formation of skin ...
| PowerPoint PPT presentation | free to download
Safety Pharmacology for Oncology Pharmaceuticals at CDER PowerPoint PPT Presentation
Safety Pharmacology for Oncology Pharmaceuticals at CDER - Oncology Drugs. Safety Pharmacology for 'cytotoxics' ... Oncology Drugs ... Oncology Biologics. ICH S6 ' ...
Oncology Drugs. Safety Pharmacology for 'cytotoxics' ... Oncology Drugs ... Oncology Biologics. ICH S6 ' ...
| PowerPoint PPT presentation | free to download
BIORESEARCH MONITORING PowerPoint PPT Presentation
BIORESEARCH MONITORING - BIORESEARCH MONITORING & IN VITRO DIAGNOSTIC DEVICES Presented by Jean Toth-Allen, Ph.D. Biophysicist/Consumer Safety Officer Division of Bioresearch Monitoring
BIORESEARCH MONITORING & IN VITRO DIAGNOSTIC DEVICES Presented by Jean Toth-Allen, Ph.D. Biophysicist/Consumer Safety Officer Division of Bioresearch Monitoring
| PowerPoint PPT presentation | free to download
Advisory Committee Role in Facilitating FDA Scientific Collaboration Concept and Proposal for a Pharmaceutical Science Subcommittee  Science Advisory Board to the NCTR June 11, 2001 James T. MacGregor, Ph.D., D.A.B.T. Deputy Director, NCTR Washington PowerPoint PPT Presentation
Advisory Committee Role in Facilitating FDA Scientific Collaboration Concept and Proposal for a Pharmaceutical Science Subcommittee Science Advisory Board to the NCTR June 11, 2001 James T. MacGregor, Ph.D., D.A.B.T. Deputy Director, NCTR Washington - Advisory Committee Role in Facilitating FDA Scientific ... Steer collaborative projects. Convene workshops, symposia. Facilitate reporting & recommendations ...
Advisory Committee Role in Facilitating FDA Scientific ... Steer collaborative projects. Convene workshops, symposia. Facilitate reporting & recommendations ...
| PowerPoint PPT presentation | free to download
PharmacologyToxicology information to submit an IND for an anticancer drug PowerPoint PPT Presentation
PharmacologyToxicology information to submit an IND for an anticancer drug - This presentation is not an official FDA guidance or policy statement. ... http://www.fda.gov/cder/about/smallbiz/Econonic.htm ...
This presentation is not an official FDA guidance or policy statement. ... http://www.fda.gov/cder/about/smallbiz/Econonic.htm ...
| PowerPoint PPT presentation | free to view
Good Laboratory Practices (GLPs) PowerPoint PPT Presentation
Good Laboratory Practices (GLPs) - Until the mid 1970's the Food and Drug Administration (FDA) ... Two submissions aroused suspicion and resulted in 'for cause' inspections of sponsor laboratory ...
Until the mid 1970's the Food and Drug Administration (FDA) ... Two submissions aroused suspicion and resulted in 'for cause' inspections of sponsor laboratory ...
| PowerPoint PPT presentation | free to view
CDER IND/NDA Reviews Guidance, The Common Technical Document and Good Review Practice PowerPoint PPT Presentation
CDER IND/NDA Reviews Guidance, The Common Technical Document and Good Review Practice - Common Technical Document. CDER Pharmacology Good Review Practice. Review Team. Project ... The Common Technical Document ... Modules 2-5 common to all regions ...
Common Technical Document. CDER Pharmacology Good Review Practice. Review Team. Project ... The Common Technical Document ... Modules 2-5 common to all regions ...
| PowerPoint PPT presentation | free to view
Perspectives on Licensing Vaccines by the Animal Rule PowerPoint PPT Presentation
Perspectives on Licensing Vaccines by the Animal Rule - 1. Proprietary. 1. Perspectives on Licensing Vaccines by the Animal Rule. Mary Kate Hart, Ph.D. ... Vaccine development by DynPort Vaccine Company LLC (DVC) ...
1. Proprietary. 1. Perspectives on Licensing Vaccines by the Animal Rule. Mary Kate Hart, Ph.D. ... Vaccine development by DynPort Vaccine Company LLC (DVC) ...
| PowerPoint PPT presentation | free to view
Overview of Drug Development: the Regulatory Process PowerPoint PPT Presentation
Overview of Drug Development: the Regulatory Process - Provides the data the FDA will base its go/no-go decision on (pivotal) ... The New Drug Development Process http://www.fda.gov/cder/handbook/develop.htm ...
Provides the data the FDA will base its go/no-go decision on (pivotal) ... The New Drug Development Process http://www.fda.gov/cder/handbook/develop.htm ...
| PowerPoint PPT presentation | free to download
Wei Liang, Ph.D. PowerPoint PPT Presentation
Wei Liang, Ph.D. - Mitochondrial Manipulation Technologies: Preclinical Considerations Wei Liang, Ph.D. FDA / CBER / OCTGT Wei.liang@fda.hhs.gov Ethical and Social Policy Considerations ...
Mitochondrial Manipulation Technologies: Preclinical Considerations Wei Liang, Ph.D. FDA / CBER / OCTGT Wei.liang@fda.hhs.gov Ethical and Social Policy Considerations ...
| PowerPoint PPT presentation | free to view
Drug Metabolites: A Regulatory Perspective on Why, How, and When to Test Their Safety PowerPoint PPT Presentation
Drug Metabolites: A Regulatory Perspective on Why, How, and When to Test Their Safety - Acetaminophen-induced hepatotoxicity is due to its reactive intermediate, ... metablites in urine, which constitutes 9% of a therapeutic dose of acetaminophen. ...
Acetaminophen-induced hepatotoxicity is due to its reactive intermediate, ... metablites in urine, which constitutes 9% of a therapeutic dose of acetaminophen. ...
| PowerPoint PPT presentation | free to view
Good Laboratory Practices (GLP) and USP 1058 Validation PowerPoint PPT Presentation
Good Laboratory Practices (GLP) and USP 1058 Validation - This webinar will define what is the US FDA's expectations for proper laboratory practices, systems, equipment usage, and documentation / record-keeping. It will evaluate the requirements for how basic Quality Management System (QMS) expectations/requirements are addressed in the lab environment. The webinar with evaluate pharma GMPs and 21 CFR 58 and associated regulations to see how the GLPs can be implemented in the real world to achieve FDA requirements and ensure the accuracy and repeatability/reproducibility of lab results.
This webinar will define what is the US FDA's expectations for proper laboratory practices, systems, equipment usage, and documentation / record-keeping. It will evaluate the requirements for how basic Quality Management System (QMS) expectations/requirements are addressed in the lab environment. The webinar with evaluate pharma GMPs and 21 CFR 58 and associated regulations to see how the GLPs can be implemented in the real world to achieve FDA requirements and ensure the accuracy and repeatability/reproducibility of lab results.
| PowerPoint PPT presentation | free to download
Investigational New Drug Applications FDA Trends and Clinical Issues PowerPoint PPT Presentation
Investigational New Drug Applications FDA Trends and Clinical Issues - Investigational New Drug Applications FDA Trends and Clinical Issues
Investigational New Drug Applications FDA Trends and Clinical Issues
| PowerPoint PPT presentation | free to view
Current Trends in Enforcement PowerPoint PPT Presentation
Current Trends in Enforcement - Foreign regulation of financial relationships with the medical profession ... No quid pro quo. Avoid appearance of improper purpose. Other factors. 5 ...
Foreign regulation of financial relationships with the medical profession ... No quid pro quo. Avoid appearance of improper purpose. Other factors. 5 ...
| PowerPoint PPT presentation | free to download
Preclinical Testing of Drugs PowerPoint PPT Presentation
Preclinical Testing of Drugs - ... 3 3f333 f3 f 3 f 3 f 3 f f f ff f3 f 3 3 ... ffff fffff3fff3 f3f3 f3ff33f3f ff fff3f3 3 3 3 f3 33 3 33 3f3333 3 ...
... 3 3f333 f3 f 3 f 3 f 3 f f f ff f3 f 3 3 ... ffff fffff3fff3 f3f3 f3ff33f3f ff fff3f3 3 3 3 f3 33 3 33 3f3333 3 ...
| PowerPoint PPT presentation | free to view
PulmonaryAllergy Drugs Advisory Committee PowerPoint PPT Presentation
PulmonaryAllergy Drugs Advisory Committee - Mechanism of lymphoma formation appears to be the same for monkeys and humans ... IRLD was noted in a 9 month oral monkey toxicology study conducted with pimecrolimus ...
Mechanism of lymphoma formation appears to be the same for monkeys and humans ... IRLD was noted in a 9 month oral monkey toxicology study conducted with pimecrolimus ...
| PowerPoint PPT presentation | free to view
ICH and CTD PowerPoint PPT Presentation
ICH and CTD - Title: No Slide Title Author: J. L. Saillot Last modified by: nm95847 Created Date: 7/3/2001 12:06:35 AM Document presentation format: On-screen Show
Title: No Slide Title Author: J. L. Saillot Last modified by: nm95847 Created Date: 7/3/2001 12:06:35 AM Document presentation format: On-screen Show
| PowerPoint PPT presentation | free to download
Advisory Committee for Pharmaceutical Science PharmacologyToxicology Subcommittee Meeting June 10, 2 PowerPoint PPT Presentation
Advisory Committee for Pharmaceutical Science PharmacologyToxicology Subcommittee Meeting June 10, 2 - Should CDER be proactive in enabling the incorporation of toxicogenomics data ... and (c) necessary for CDER to set a goal of developing an internal database to ...
Should CDER be proactive in enabling the incorporation of toxicogenomics data ... and (c) necessary for CDER to set a goal of developing an internal database to ...
| PowerPoint PPT presentation | free to download
Good Laboratory Practice is a internationally standard for a preclinical testing PowerPoint PPT Presentation
Good Laboratory Practice is a internationally standard for a preclinical testing - Good Laboratory Practice is a internationally standard for a preclinical testing ... Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry (BRANCH) Russian ...
Good Laboratory Practice is a internationally standard for a preclinical testing ... Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry (BRANCH) Russian ...
| PowerPoint PPT presentation | free to view
Cellular Therapies for Repair and Regeneration of Joint Surfaces  PowerPoint PPT Presentation
Cellular Therapies for Repair and Regeneration of Joint Surfaces - Cellular Therapies for Repair and Regeneration of Joint Surfaces FDA Clinical Perspective ... Cartilage Repair/Regeneration. MRI. Arthroscopy. Histology ...
Cellular Therapies for Repair and Regeneration of Joint Surfaces FDA Clinical Perspective ... Cartilage Repair/Regeneration. MRI. Arthroscopy. Histology ...
| PowerPoint PPT presentation | free to download
?????????????? ???????????? ???????? (GLP, Good Laboratory Practice)  PowerPoint PPT Presentation
?????????????? ???????????? ???????? (GLP, Good Laboratory Practice) - Title: Last modified by: . . Document presentation format:
Title: Last modified by: . . Document presentation format:
| PowerPoint PPT presentation | free to view
Toxicity Testing PowerPoint PPT Presentation
Toxicity Testing - Alternatives to Animal Testing Toxicologists as well as other scientists who use animals for research and testing purposes have been encouraged to explore the 3R ...
Alternatives to Animal Testing Toxicologists as well as other scientists who use animals for research and testing purposes have been encouraged to explore the 3R ...
| PowerPoint PPT presentation | free to view
FDA Regulation of Pharmaceuticals and Devices PowerPoint PPT Presentation
FDA Regulation of Pharmaceuticals and Devices - FDA Regulation of Pharmaceuticals and Devices Jean Toth-Allen, Ph.D. Good Clinical Practice Program Office of Science and Health Coordination Office of the Commissioner
FDA Regulation of Pharmaceuticals and Devices Jean Toth-Allen, Ph.D. Good Clinical Practice Program Office of Science and Health Coordination Office of the Commissioner
| PowerPoint PPT presentation | free to view
Integrating Scientific Advances into Regulation: Pharmacogenomics and Pharmacogenetics PowerPoint PPT Presentation
Integrating Scientific Advances into Regulation: Pharmacogenomics and Pharmacogenetics - Integrating Scientific Advances into Regulation: Pharmacogenomics and Pharmacogenetics ... STET and gene expression screening. Obligations of Drug Regulators ...
Integrating Scientific Advances into Regulation: Pharmacogenomics and Pharmacogenetics ... STET and gene expression screening. Obligations of Drug Regulators ...
| PowerPoint PPT presentation | free to view
Human Embryonic Stem Cells: Considerations for Therapeutic Development PowerPoint PPT Presentation
Human Embryonic Stem Cells: Considerations for Therapeutic Development - ... Target Site for Activity? Final Product Production Scale: ... Activity in Disease Models. Clinical Efficacy. Histological Efficacy. Dose. Human Equivalent Dose ...
... Target Site for Activity? Final Product Production Scale: ... Activity in Disease Models. Clinical Efficacy. Histological Efficacy. Dose. Human Equivalent Dose ...
| PowerPoint PPT presentation | free to view
Page of  


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2025 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
nonclinical studies — Search results on PowerShow.com
Loading...